Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited. The company’s business operations are carried in over 30 countries including 11 offices located in India
Strengths
- +Company's working capital requirements have reduced from 20.9 days to 11.2 days
Weaknesses
- −Company has a low return on equity of 7.72% over last 3 years.
- −Dividend payout has been low at 11.5% of profits over last 3 years
- −Promoter holding has decreased over last 3 years: -3.15%
Shareholding Pattern
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 69.55% | 69.5%▼0.0 | 69.39%▼0.1 | 69.39% | 69.38%▼0.0 | 69.36%▼0.0 | 69.36% | 69.36% |
| FIIs | 1.05% | 1.67%▲0.6 | 1.97%▲0.3 | 2.48%▲0.5 | 1.63%▼0.9 | 1.6%▼0.0 | 1.6% | 1.16%▼0.4 |
| DIIs | 2.16% | 3.22%▲1.1 | 3.47%▲0.3 | 3.38%▼0.1 | 4.05%▲0.7 | 3.19%▼0.9 | 3.4%▲0.2 | 3.82%▲0.4 |
| Public | 27.25% | 25.61%▼1.6 | 25.17%▼0.4 | 24.75%▼0.4 | 24.93%▲0.2 | 25.85%▲0.9 | 25.65%▼0.2 | 25.68%▲0.0 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 636 | 686 | 811 | 717 | 744 | 768 | 714 | 672 | 706 | 707 |
| Expenses | 588 | 628 | 723 | 635 | 672 | 695 | 655 | 638 | 666 | 660 |
| Operating Profit | 48 | 58 | 88 | 82 | 72 | 72 | 59 | 34 | 40 | 47 |
| OPM % | 8% | 8% | 11% | 11% | 10% | 9% | 8% | 5% | 6% | 7% |
| Net Profit | 23 | 39 | 47 | 46 | 27 | 28 | 28 | 23 | 14 | 20 |
| EPS ₹ | 0.88 | 1.42 | 1.72 | 1.68 | 0.96 | 1 | 1.03 | 0.83 | 0.5 | 0.72 |
AI Insights
TTM revenue at ₹2,799Cr, down 5% YoY. OPM at 6%.
Borrowings at ₹331Cr. Debt-to-equity ratio: 0.18x. Healthy balance sheet.
CWIP at ₹483Cr (34% of fixed assets). Significant capex underway — growth runway building.
DIIs: 3.82% (+2.28pp change). FIIs: 1.16% (+0.68pp change). Promoters hold 69.36%.
ROCE improving from 0% (Mar 2016) to 9% (Mar 2025). Working capital days: 11.
PE 49.1x with 8.77% ROCE. Price is 116% above book value of ₹70. Dividend yield: 0.32%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 May - The officials of the Company will be meeting for Investor & Analyst Meet to discuss performance for the quarter and year ended March 31, 2026, …
- Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026. 5 May - Board meets May 21, 2026 to approve FY26 audited results and dividend recommendation.
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 13 Apr - Mahadeo Karnik resigned as CFO effective April 13, 2026; Harshvardhan Goenka appointed interim CFO from April 14, 2026.
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 10 Apr - CFO Mahadeo Karnik resigns April 13, 2026; Harshvardhan Goenka appointed interim CFO from April 14.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026; no demat requests received.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse